
Propranolol Action Pathway (New - beta blocker)
Propranolol Pathway (New - beta blocker) References
Stoschitzky K, Lindner W, Egginger G, Brunner F, Obermayer-Pietsch B, Passath A, Klein W: Racemic (R,S)-propranolol versus half-dosed optically pure (S)-propranolol in humans at steady state: Hemodynamic effects, plasma concentrations, and influence on thyroid hormone levels. Clin Pharmacol Ther. 1992 Apr;51(4):445-53. doi: 10.1038/clpt.1992.45.
Spiteri Cornish K, Reddy AR: The use of propranolol in the management of periocular capillary haemangioma--a systematic review. Eye (Lond). 2011 Oct;25(10):1277-83. doi: 10.1038/eye.2011.164. Epub 2011 Jul 8.
Martin N, Manoharan K, Thomas J, Davies C, Lumbers RT: Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction. Cochrane Database Syst Rev. 2018 Jun 28;6:CD012721. doi: 10.1002/14651858.CD012721.pub2.
Fukuta H, Goto T, Wakami K, Kamiya T, Ohte N: Effect of beta-blockers on heart failure severity in patients with heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials. Heart Fail Rev. 2021 Jan;26(1):165-171. doi: 10.1007/s10741-020-10013-5.
Gorre F, Vandekerckhove H: Beta-blockers: focus on mechanism of action. Which beta-blocker, when and why? Acta Cardiol. 2010 Oct;65(5):565-70. doi: 10.1080/ac.65.5.2056244.
Zicha S, Tsuji Y, Shiroshita-Takeshita A, Nattel S: Beta-blockers as antiarrhythmic agents. Handb Exp Pharmacol. 2006;(171):235-66.
O'Connor PC, Finch MJ, Harron DW, Meredith PA, McDevitt DG, Shanks RG: Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers. Br J Clin Pharmacol. 1985 Dec;20(6):659-67. doi: 10.1111/j.1365-2125.1985.tb05125.x.
Tuross N, Patrick RL: Effects of propranolol on catecholamine synthesis and uptake in the central nervous system of the rat. J Pharmacol Exp Ther. 1986 Jun;237(3):739-45.
Szentmiklosi AJ, Szentandrassy N, Hegyi B, Horvath B, Magyar J, Banyasz T, Nanasi PP: Chemistry, physiology, and pharmacology of beta-adrenergic mechanisms in the heart. Why are beta-blocker antiarrhythmics superior? Curr Pharm Des. 2015;21(8):1030-41. doi: 10.2174/1381612820666141029111240.
Rath G, Balligand JL, Dessy C: Vasodilatory mechanisms of beta receptor blockade. Curr Hypertens Rep. 2012 Aug;14(4):310-7. doi: 10.1007/s11906-012-0278-3.